Strides Pharma Science informs about press release

24 Jun 2022 Evaluate

Strides Pharma Science has informed that it Press Release issued by the Company titled ‘Biolexis and Akston Biosciences Announce Encouraging Top-Line Results from Phase II/III Trial of their Thermostable 2nd Gen COVID-19 Vaccine’.

The above information is a part of company’s filings submitted to BSE.

Strides Pharma Scien Share Price

793.30 -2.90 (-0.36%)
27-Jan-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1636.05
Dr. Reddys Lab 1240.00
Cipla 1313.20
Zydus Lifesciences 895.85
Lupin 2147.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×